Science Explorer Back to mapMap
Discussion
Researcher · Universitat Autònoma de Barcelona · Spain

Manuel Comabella

Manuel Comabella publishes mostly in Pathology and Forensic Medicine, Molecular Biology and Neurology, on topics such as Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders and Polyomavirus and related diseases.

ORCID 0000-0002-2373-6657 OpenAlex
World rank
#150,815
of 7,710,434 ranked researchers
Rank in Spain
#2,145
of 204,306
Works
374
Citations
24k
Citations per work
63.6
h-index
69
i10-index 239Top 1.8% in Pathology and Forensic Medicine
Manuel Comabella

What does Manuel Comabella research?

Manuel Comabella's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (11%).

Health Sciences: 177 works · 47.3% of their workMedicine: 177 works · 47.3% of their workPathology and Forensic Medicine: 85 works · 22.6% of their workNeurology: 43 works · 11.4% of their workOncology: 29 works · 7.7% of their workRheumatology: 21 works · 5.6% of their workEverything else: 104 works · 27.9% of their workLife Sciences: 93 works · 24.8% of their workBiochemistry, Genetics and Molecular Biology: 50 works · 13.4% of their workMolecular Biology: 50 works · 13.4% of their workImmunology and Microbiology: 43 works · 11.4% of their workImmunology: 43 works · 11.4% of their workTHEIR WORKManuel Comabella374works
Life Sciences25%Health Sciences47%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine17747.3%
  2. Everything else10427.9%
    1. Biochemistry, Genetics and Molecular Biology5013.4%
    2. Immunology and Microbiology4311.4%
  1. 1Pathology and Forensic Medicine23% of their works
  2. 2Molecular Biology13% of their works
  3. 3Neurology11% of their works
  4. 4Immunology11% of their works
  5. 5Oncology8% of their works
  6. 6Rheumatology6% of their works

Research topics

Which keywords describe Manuel Comabella's research?

The keywords of their largest research topics: Diagnostic Criteria, Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Guillain-Barré Syndrome, Merkel Cell Carcinoma, Polyomavirus, Antiphospholipid Syndrome and Systemic Lupus Erythematosus.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Diagnostic Criteria2191 topic
  2. Multiple Sclerosis2191 topic
  3. Chronic Inflammatory Demyelinating Polyradiculoneuropathy641 topic
  4. Guillain-Barré Syndrome641 topic
  5. Merkel Cell Carcinoma331 topic
  6. Polyomavirus331 topic
  7. Antiphospholipid Syndrome321 topic
  8. Systemic Lupus Erythematosus321 topic
  9. IL-6301 topic
  10. STAT3301 topic
  11. FUS/TLS291 topic
  12. TDP-43291 topic
  13. Dendritic Cells281 topic
  14. Immunity281 topic
  15. Foxp3241 topic
  16. TGF-ß241 topic

Where does Manuel Comabella work?

Manuel Comabella's main affiliation in the publication record is Universitat Autònoma de Barcelona, Spain.

How many publications and citations does Manuel Comabella have?

OpenAlex counts 374 works and 23,778 citations for Manuel Comabella, an h-index of 69, ranking #150,815 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Manuel Comabella. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.